Immune dysregulation is a hallmark of human immunodeficiency virus (HIV) infection, characterized by persistent immune activation and systemic inflammation that drive T cell exhaustion and senescence, contributing to disease progression and non-AIDS comorbidities, most notably tuberculosis (TB). With rising HIV prevalence, the incidence of HIV-TB co-infection continues to rise, highlighting the need to understand their immunopathological interplay. This narrative review aims to examine the association between immune dysregulation in HIV-TB co-infection, with a focus on cytokine profiles and immunological biomarkers. Relevant literature was retrieved from multiple databases, with evidence demonstrating differential expression of cytokines—IL-17A, IFN-γ, TNF, IL-10, IL-6, IL-4, and IL-2—and T cell activation markers, such as CD38 and HLA-DR on CD4+ T cells in latent and active TB among HIV-infected individuals. These immune mediators are consistently co-expressed at higher levels in active TB compared to latent TB, suggesting heightened immune activation of both innate and adaptive immune responses in HIV-TB co-infection. However, these findings are largely based on observational data, and the precise mechanism by which cytokine and T cell biomarker dysregulation contributes to HIV-TB pathogenesis remains incompletely understood, underscoring the need for larger, mechanistic studies to address these gaps in the pathogenic pathway.
30 June 2025 in Biomedical and Pharmacology Journal
Multiple myeloma (MM) is a hematological malignancy characterized by the clonal proliferation of plasma cells and the excessive accumulation of monoclonal protein. While primary manifestations such as bone pain, renal dysfunction, anemia are well-documented features, extra-hematological complications, including achalasia, are exceedingly rare. We present a 76-year-old male with 10-month history of persistent dysphagia. Laboratory test revealed anemia, leukocytosis, and neutrophilia, while serum protein electrophoresis indicated dysproteinemia. Bone marrow aspiration confirmed MM with 25% plasma cell infiltration. Imaging and endoscopic findings further identified a lytic cervical spine lesion and esophageal motility dysfunction consistent with achalasia. This case presents a rare presentation extra-hematological presentation of MM, emphasizing the need for a comprehensive diagnostic approach to facilitate timely recognition and appropriate management of MM.
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, and the molecular mechanisms driving its progression and metastasis remain incompletely understood. Increasing evidence highlights the role of IQ motif-containing GTPase-activating proteins (IQGAPs)—a family of scaffold proteins consisting of IQGAP1, IQGAP2, and IQGAP3—in regulating multiple signaling pathways involved in tumor development. This narrative review provides an overview of the molecular roles of IQGAP family proteins in CRC, focusing on their involvement in oncogenic signaling and their potential prognostic significance. Current evidence suggests that IQGAP family members play distinct and sometimes opposing roles in CRC biology. IQGAP1 is frequently overexpressed and acts as a scaffold that activates ERK/MAPK and β-catenin signaling, promoting proliferation, invasion, and metastasis. In contrast, IQGAP2 exhibits tumor-suppressive properties, with reduced expression associated with more aggressive disease and unfavorable outcomes. Meanwhile, IQGAP3 has emerged as a potential oncogenic driver, where its upregulation correlates with enhanced tumor growth, metastatic potential, and poorer survival, possibly through PI3K-related signaling. Together, these findings highlight the context-dependent roles of IQGAP proteins in CRC and suggest their potential as novel biomarkers and therapeutic targets. Further validations are needed to explore the clinical utility of IQGAP proteins in CRC.